Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

What We Have Learned about Electroconvulsive Therapy and its Relevance for the Practising Psychiatrist

(2017) Pascal Sienaert   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

A Psychobiological Rationale for Oxytocin in the Treatment of Posttraumatic Stress Disorder.

(2017) Miranda Olff et al.   CNS SPECTRUMS

MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions

(2012) Cédric M. Hysek et al.   PSYCHOPHARMACOLOGY

The placebo response: How words and rituals change the patient's brain

(2011) Fabrizio Benedetti et al.   PATIENT EDUCATION AND COUNSELING

A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans

(2011) Matthew G. Kirkpatrick et al.   PSYCHOPHARMACOLOGY

Interaction between expectancies and drug effects: an experimental investigation of placebo analgesia with caffeine as an active placebo

(2011) Espen Bjørkedal et al.   PSYCHOPHARMACOLOGY

Long-Term Abstinence Following Holotropic Breathwork as Adjunctive Treatment of Substance Use Disorders and Related Psychiatric Comorbidity

(2011) Timothy D. Brewerton et al.   International Journal of Mental Health and Addiction

Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs

(2010) John H. Halpern et al.   ADDICTION

Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others

(2010) Gillinder Bedi et al.   BIOLOGICAL PSYCHIATRY

Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study

(2010) Stephen J. Kish et al.   BRAIN

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

(2010) Michael C Mithoefer et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)

(2010) Erich Studerus et al.   PLoS One

Deficits of long-term memory in ecstasy users are related to cognitive complexity of the task

(2010) John Brown et al.   PSYCHOPHARMACOLOGY

Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor

(2009) Karen L. Hanson et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

Physiological and Subjective Responses to Controlled Oral 3,4-Methylenedioxymethamphetamine Administration

(2009) Erin A. Kolbrich et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Effects of MDMA on sociability and neural response to social threat and social reward

(2009) Gillinder Bedi et al.   PSYCHOPHARMACOLOGY

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration

(2009) G. J. H. Dumont et al.   Social Neuroscience

Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study

(2008) S. de Sola LLopis et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Treatment of post-traumatic stress disorder with eye movement desensitization and reprocessing: Outcome is stable in 35-month follow-up

(2008) Göran Högberg et al.   PSYCHIATRY RESEARCH

Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds

(2008) G. Bedi et al.   PSYCHOLOGICAL MEDICINE

A Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought

(2007) Donald D. Price et al.   Annual Review of Psychology